计算机断层扫描在评估急诊科就诊的COVID-19患者死亡风险中的价值
本研究纳入2020年2月27日至3月23日意大利雷焦艾米利亚省五家急诊科连续就诊的866例疑似COVID-19且拭子阳性患者,回顾性分析临床变量与CT病变范围对死亡的预测价值。多变量Cox模型显示CT病变范围≥60%与死亡独立相关(HR=7.56),但将CT范围加入临床模型后cvAUC仅从0.927升至0.936,提示CT增益有限。
要点
- CT病变范围≥60%与死亡独立相关(HR=7.56),但加入临床模型后预测准确性提升有限。
- 基于年龄、性别、合并症、症状天数和实验室指标的临床模型预测死亡高度准确(cvAUC=0.927)。
- 急诊COVID-19患者CT范围分级为<20%、20-39%、40-59%、≥60%,用于风险分层。
核心结论
- 基于临床变量的预后模型能高度准确预测COVID-19患者死亡,加入CT病变范围后模型准确性提升甚微。
研究设计与样本
- 回顾性研究,纳入2020年2月27日至3月23日意大利雷焦艾米利亚省五家急诊科连续就诊的866例疑似COVID-19、接受胸部CT且10天内拭子阳性的患者,中位年龄59.8岁,女性占39.2%。
关键影像表现/征象
- CT病变范围视觉分级为<20%、20-39%、40-59%、≥60%。
- CT病变范围≥60%与死亡独立相关(HR=7.56,95%CI=3.49;16.38)。
诊断标准与关键数值
- 多变量模型中与死亡显著相关的临床变量包括年龄、男性、HDL胆固醇、痴呆、心力衰竭、血管疾病、症状出现时间、中性粒细胞、LDH和氧饱和度水平。
- 临床模型cvAUC=0.927(bootstrap偏倚校正95%CI=0.899-0.947)。
- 加入CT范围后模型cvAUC=0.936(bootstrap偏倚校正95%CI=0.912-0.953)。
临床应用与阅片要点
- 急诊COVID-19患者可依据年龄、性别、合并症、症状天数和实验室指标评估死亡风险。
- CT病变范围≥60%提示死亡风险增高,但作为增量指标对模型准确性提升有限。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aims of this study were to develop a multiparametric prognostic model for death in COVID-19 patients and to assess the incremental value of CT disease extension over clinical parameters.
METHODS: Consecutive patients who presented to all five of the emergency rooms of the Reggio Emilia province between February 27 and March 23, 2020, for suspected COVID-19, underwent chest CT, and had a positive swab within 10 days were included in this retrospective study. Age, sex, comorbidities, days from symptom onset, and laboratory data were retrieved from institutional information systems. CT disease extension was visually graded as < 20%, 20-39%, 40-59%, or ≥ 60%. The association between clinical and CT variables with death was estimated with univariable and multivariable Cox proportional hazards models; model performance was assessed using k-fold cross-validation for the area under the ROC curve (cvAUC).
RESULTS: Of the 866 included patients (median age 59.8, women 39.2%), 93 (10.74%) died. Clinical variables significantly associated with death in multivariable model were age, male sex, HDL cholesterol, dementia, heart failure, vascular diseases, time from symptom onset, neutrophils, LDH, and oxygen saturation level. CT disease extension was also independently associated with death (HR = 7.56, 95% CI = 3.49; 16.38 for ≥ 60% extension). cvAUCs were 0.927 (bootstrap bias-corrected 95% CI = 0.899-0.947) for the clinical model and 0.936 (bootstrap bias-corrected 95% CI = 0.912-0.953) when adding CT extension.
CONCLUSIONS: A prognostic model based on clinical variables is highly accurate in predicting death in COVID-19 patients. Adding CT disease extension to the model scarcely improves its accuracy.
KEY POINTS: • Early identification of COVID-19 patients at higher risk of disease progression and death is crucial; the role of CT scan in defining prognosis is unclear. • A clinical model based on age, sex, comorbidities, days from symptom onset, and laboratory results was highly accurate in predicting death in COVID-19 patients presenting to the emergency room. • Disease extension assessed with CT was independently associated with death when added to the model but did not produce a valuable increase in accuracy.
引用
- Besutti G, Ottone M, Fasano T, et al. The value of computed tomography in assessing the risk of death in COVID-19 patients presenting to the emergency room. Eur Radiol. 2021. PMID: 33978822. doi:10.1007/s00330-021-07993-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。